Stroke Treatment Academic Industry Roundtable

October 1-2, 2020 


STAIR XI was rescheduled from its original date of March 23-24 and will now be convened on October 1-2, 2020 as a virtual conference entitled CYBER STAIR XI. All conference faculty have been confirmed, all corporate sponsors remain resolute in their support of STAIR XI and the robust program is well established, albeit with flexibility to incorporate significant new R&D, regulatory changes or clinical developments that may arise prior to the meeting.

STAIR XI promises to be one of the most important STAIR conferences to date because recent stroke clinical trials have dramatically altered the landscape in our understanding of the stroke treatment time window. This new "transparent time window" significantly impacts study design, objectives and outcomes determination as well as cross-industry device and drug company collaborations including imaging integration.


STAIR XI will lead in developing new strategies incorporating these breakthroughs. This new frontier raises important questions, poses unique challenges and presents new opportunities to the stroke research, development and treatment communities which STAIR XI will address.


The Transparent Time Window -

New Perspectives in Reperfusion, Neuroprotection and Imaging 


The five main conference sessions with over 20 presentations will address the following critical concerns:

  1. Acute Stroke Trials: New Data, New Landscape, New Designs

  2. Neuroprotection: Preclinical and Clinical Evaluation in 2020

  3. Role of Imaging in Recent and Future Clinical Trials

  4. Intravenous Thrombolysis Trial Design plus NINDS - STEP Platform

  5. Regulatory Perspectives on Clinical Trial Issues:

  • Image-based Subject Selection

  • Drug, Device and Combined Study Regulations and Policies


Consensus Workshops to Develop Recommendations

Consensus Workshop 1:  

Top Priorities for Neuroprotective Studies

Facilitators – Chair: Pat Lyden  Co-chair: Eng Lo

Consensus Workshop 2:

Imaging Workshop - The Time Window Gets Transparent

Facilitators – Chair: Bruce Campbell   Co-chair: Maarten Lansberg 

Consensus Workshop 3: 

How to Establish the "Outer Limits" of Reperfusion Therapies

Facilitators – Chair: Larry Wechsler     Co-chair: Tudor Jovin

True to the STAIR model, via a facilitated consensus process, participants will develop recommendations covering the most compelling and timely questions facing the field today. The final manuscripts containing these consensus statements will be published in the journal Stroke. Participants may be listed as contributors in these publications.

The information contained in this website reflects opinions of STAIR participants regarding the process of conducting research and development into existing, new and prospective drugs and devices for the treatment of stroke. The information is not intended to be a substitute for rigorous independent testing and development of individual compounds and devices by research sponsors, nor should the information and opinions be construed as official government regulations or official interpretations of government regulations. All government regulations and their applications to specific research studies and clinical trials are subject to individual deliberations between study sponsors and government agencies. The information contained in this website is not intended to be a substitute for sound medical advice, clinical judgment or informed treatment decisions.

STAIR® is a Registered Trademark of The Stroke Group.   

© 2020 The Stroke Group